Related Experiment Video

Updated: Jan 7, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.2K

Selecting optimal therapy for chronic neutrophilic leukemia: new prospects based on genetic and molecular makeup

Moza Hamoud1, Victor M Samperio1, Ifeoma Ike1

  • 1Department of Medicine, Eisenhower Health, Rancho Mirage, CA, USA.

Expert Opinion on Pharmacotherapy
|December 14, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CSF3R mutationChronic neutrophilic leukemiahydroxyurearuxolitinibsupportive care

More Related Videos

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

15.7K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.6K

Related Experiment Videos

Last Updated: Jan 7, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.2K
Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

15.7K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.6K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

Articles linked to this work by shared authors, journal, and citation graph.

Expanding indications of immune checkpoint inhibitors: a decade of success going strong.

Expert opinion on biological therapy·2026

Mantle Cell Lymphoma in Geriatric Patients: Biologic Risk Stratification, Fitness-Adapted Strategies, and Unmet Needs.

European journal of haematology·2026

Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

Expert opinion on biological therapy·2026

The interplay between bile acid metabolism and gut microbiome in biliary tract cancers.

Frontiers in microbiomes·2026

Updates in the pharmacologic management of various Castleman disease subtypes: A comprehensive review.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Case Report: An interesting case of vision and hearing loss revealing CNS recurrence in Philadelphia-positive acute lymphoblastic leukemia.

Frontiers in oncology·2026

Evaluating enlicitide decanoate: first oral PCSK9 inhibitor for the treatment of adults with hypercholesterolemia.

Expert opinion on pharmacotherapy·2026

Pharmacological solutions for vitiligo: emerging role of Janus kinase inhibitors.

Expert opinion on pharmacotherapy·2026

Evaluating bezuclastinib for the treatment of advanced gastrointestinal stromal tumours.

Expert opinion on pharmacotherapy·2026

Evaluating the combination of bictegravir and lenacapavir as a single tablet option for HIV.

Expert opinion on pharmacotherapy·2026

Pharmacotherapy for chronic migraine prevention: a narrative review.

Expert opinion on pharmacotherapy·2026

Contemporary pharmacological management of anemia associated with chronic kidney disease.

Expert opinion on pharmacotherapy·2026

Monocytic Cell Variations in Postallotransplant Environment: Balancing Graft Versus Host Disease and Graft-Versus-Leukemia Effect.

Journal of immunology research·2026

Early antithrombin depletion after trauma is associated with biomarkers of endotheliopathy and systemic protein loss: a retrospective observational study.

Shock (Augusta, Ga.)·2026

Establishment of Reference Intervals for Thrombus Biomarkers in a Single-Center Chinese Population Using Indirect Methods.

Journal of clinical laboratory analysis·2026

Re-evaluating haemolysis rejection criteria for PT, aPTT, and D-dimer testing: evidence from paired clinical samples on the CN-3000 analyser.

Advances in laboratory medicine·2026

Diagnostic Utility of Platelet Indices in Differentiating Hypoproductive and Hyperdestructive Thrombocytopenia: A Cross-Sectional Study From North India.

Cureus·2026

Medium-term biological variation of sodium, potassium and chloride in whole blood in cohorts of healthy individuals and hemodialysis patients.

Advances in laboratory medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us